W7N-40534-97264 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Left axillary lymphadenopathy and associated pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches, Fatigue or tiredness

Free text: Left axillary adenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Free text: Left axillary lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache · Be unable to do your normal daily activities

Adult check-in
2021-01-18
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-05
Dose 3 — Pfizer-BioNTech
2022-01-12
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-16
Dose 4 — Pfizer-BioNTech
2022-09-16
Health check-in — day 0, dose 4
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-09-17
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-09-18
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2022-09-19
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-09-20
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-09-23
Health check-in — day 7, dose 4
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-09-30
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-09
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-16
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-21
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-10-28
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-16
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-03-17
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-10-05	Pfizer-BioNTech	No
4	2022-09-16	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-14	priority 2/3
2021-01-18	priority 2/3

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Left axillary lymphadenopathy and associated pain

2021-01-15

Systemic reaction (other): Left axillary adenopathy

2021-01-16

Systemic reaction (other): Left axillary lymphadenopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Axillary pain	○	○	○
SRO	Lymph node pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release